Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2677-2682, November 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poon, S. P.
Right arrow Articles by Cauchi, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poon, S. P.
Right arrow Articles by Cauchi, M. N.

Blastogenic Response of Lymphoid Cells to Tumor Cells or Tumor Membrane Extracts in Vitro1

S. P. Poon and M. N. Cauchi2

Department of Pathology, Monash University, Melbourne, Australia

The in vitro cellular response of mouse spleen cells to tumor cells or tumor membrane extract was compared using the one-way mixed culture technique. The maximal primary response of spleen cells to mitomycin C-treated Ehrlich ascites carcinoma cells in vitro occurred on the 3rd to 5th days when the spleen cells to tumor ratio was 5:1. Spleen cells from immune animals responded earlier and to a greater degree than spleen cells from normal animals. Membrane extract also stimulated spleen cells from normal animals similarly to mitomycin C-treated tumor cells but the response of spleen cells to membrane extract appeared to be limited to an antigen concentration between 0.01 and 1 µg/ml. Reduction of thymidine-3H uptake by spleen cells occurred in the presence of high concentration of tumor cells or membrane extract, indicating that these may interfere with blast transformation of lymphoid cells in vitro.

1 This work was supported by grants from the Anti-Cancer Council of Victoria and the Australian Research Grants Committee.

2 To whom requests for reprints should be addressed at Department of Pathology, Monash University Medical School, Prahran, Victoria, Australia, 3181.

Received 5/10/73. Accepted 7/18/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.